• 1. Alt-proteins: A promising future
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Dialkyl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Dialkyl ethers
• Other Chemical additives

Introduction to m-PEG10-alcohol (CAS No. 27425-92-9) and Its Recent Applications in Chemical and Biomedical Research

M-PEG10-alcohol, chemically known by its CAS number 27425-92-9, is a widely utilized polyethylene glycol (PEG) derivative that has garnered significant attention in the fields of pharmaceuticals, biotechnology, and materials science. This compound, characterized by a molecular weight of approximately 1,410.3 g/mol, features a linear structure with ten ethylene oxide units terminated by a hydroxyl group. The hydrophilic nature of PEG chains, combined with the reactivity of the terminal alcohol group, makes m-PEG10-alcohol an invaluable tool for various applications, including drug delivery systems, surface modification, and biomolecule conjugation.

The versatility of m-PEG10-alcohol stems from its ability to enhance the solubility and stability of hydrophobic molecules while simultaneously improving biocompatibility. This property has been leveraged in the development of advanced drug formulations designed to overcome pharmacokinetic challenges. Recent studies have highlighted its role in creating prodrugs that exhibit controlled release profiles, thereby improving therapeutic efficacy and reducing side effects. For instance, researchers have successfully incorporated m-PEG10-alcohol into nanocarriers to deliver chemotherapy agents more targetedly to tumor sites, minimizing systemic toxicity.

In addition to its pharmaceutical applications, m-PEG10-alcohol has found utility in biomedical imaging and diagnostics. Its ability to act as a contrast agent in magnetic resonance imaging (MRI) has been explored in preclinical studies. By conjugating m-PEG10-alcohol to imaging probes, scientists have developed more sensitive and specific diagnostic tools for detecting diseases such as cancer and neurodegenerative disorders. The prolonged circulation time provided by PEGylation enhances the visibility of these probes in imaging modalities, leading to better diagnostic outcomes.

The surface modification capabilities of m-PEG10-alcohol are another area of intense research. In materials science, PEGylation is employed to modify the surface properties of materials to improve biocompatibility and reduce protein adsorption. This has direct implications in the development of medical implants and devices. For example, studies have demonstrated that coating biomedical implants with m-PEG10-alcohol can significantly reduce fibrosis and improve long-term functionality. The hydrophilic nature of PEG chains creates a protective barrier that minimizes host responses while maintaining structural integrity.

Beyond its applications in drug delivery and diagnostics, m-PEG10-alcohol plays a crucial role in biomolecular engineering. Researchers have utilized this compound to modify antibodies and other therapeutic proteins to enhance their pharmacokinetic profiles. By attaching PEG chains via the terminal alcohol group, proteins can be rendered more stable and resistant to degradation in biological systems. This approach has been particularly effective in extending the half-life of monoclonal antibodies, thereby reducing dosing frequency and improving patient compliance.

The synthesis of m-PEG10-alcohol typically involves the polymerization of ethylene oxide followed by functionalization at one end with an alcohol group. Advances in synthetic methodologies have enabled the production of highly pure grades of PEG derivatives like m-PEG10-alcohol, ensuring consistency and reliability in research applications. Current trends in synthetic chemistry focus on developing greener and more efficient methods for PEG production, aligning with broader sustainability goals in the chemical industry.

The impact of PEGylation on protein biochemistry has been extensively studied. The addition of PEG chains can alter the conformational dynamics of proteins, affecting their binding affinity and catalytic activity. This phenomenon has been exploited in enzyme engineering to develop more robust biocatalysts for industrial processes. Furthermore, PEGylation can shield proteins from proteolytic enzymes, enhancing their stability during storage and transport.

In conclusion, m-PEG10-alcohol (CAS No. 27425-92-9) is a multifaceted compound with broad applications across chemical and biomedical research. Its ability to enhance solubility, stability, and biocompatibility makes it indispensable in drug development, diagnostics, surface engineering, and biomolecular modification. As research continues to uncover new applications for this versatile derivative, its significance is likely to grow further, driving innovation in multiple scientific disciplines.

• 125328-68-9(1,3-Benzenedicarboxylic acid, polymer with 1,3-bis(isocyanatomethyl)benzene, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,1'-[(1-methylethylidene) bis(4,1-phenyleneoxy)]bis[2-propanol] and 2,2'-oxybis[ethanol])
• 68440-92-6(OLIGO-VINYLTRIMETHOXYSILANE)
• 89769-11-9(2,5,8,11,14-Pentaoxahexadecane)
• 6812-36-8(HO-PEG16-OH)
• 123701-51-9(1,2-Benzenedicarboxylic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,1'-methylenebis[4-isocyanatobenzene], 1,1'-[(1-methylethylidene) bis(4,1-phenyleneoxy)]bis[2-propanol] and 2,2'-oxybis[ethanol])
• 37421-08-2(2-(2-ETHOXYETHOXY)ETHAN(OL-D))
• 123171-64-2(2-Oxepanone, polymer with 1,4-butanediol, 5-isocyanato-1-(isocyanatomethyl) -1,3,3-trimethylcyclohexane, 1,1'-methylenebis[4-isocyanatocyclohexane] and 2,2'-oxybis[ethanol])
• 123701-49-5(1,3-Benzenedicarboxylic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,1'-methylenebis[4-isocyanatobenzene], 1,1'-[(1-methylethylidene) bis(4,1-phenyleneoxy)]bis[2-propanol] and 2,2'-oxybis[ethanol])
• 123701-50-8(1,2-Benzenedicarboxylic acid, polymer with 1,3-diisocyanatomethylbenzene, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,1'-[(1-methylethylidene) bis(4,1-phenyleneoxy)]bis[2-propanol] and 2,2'-oxybis[ethanol])
• 123171-65-3(2-Oxepanone, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, 1,1'-methylenebis[4-isocyanatocyclohexane] and 2,2'-oxybis[ethanol])